This followed the creation of credit support intervention fund by theCentral
The product is expected to ease the facilitation of on-lending scheme targeted at individuals, businesses, manufacturers and services providers in the healthcare sector.
According to a statement, UnityCares is a credit scheme aimed at supporting indigenous pharmaceutical companies and healthcare practitioners and other value chains businesses to provide access to loan facilities of up to N2 billion per company at five per cent interest rate.
The new UnityCare product would thus cater to improve access to affordable credits by players, reduce medical tourism and conserve foreign exchange.
It is also aimed at providing long-term, low-cost finance for healthcare infrastructural development, healthcare product manufacturing, healthcare services and pharmaceutical/medical product distribution and logistics services.
"Leveraging on the
"The main target beneficiaries of the credit scheme include healthcare product manufacturers - pharmaceutical drugs and medical equipment; healthcare service providers/medical facilities such as hospitals/clinics; diagnostic centres/laboratories; fitness and wellness centres; rehabilitation centres; dialysis centres and blood bank operators.
"Others include the pharmaceutical/medical products distribution and logistics services and other human healthcare service providers as may be determined by the CBN from time to time.
"To benefit from the UnityCares facility, a healthcare organisation may not need an account with
Commenting on the new UnityCares product, Divisional Head, Retail, SME & E-business,
"We encourage operators in the health sector to take advantage of this affordable facility to expand their capacity while playing their part in curbing medical tourism and conserving the desperately-needed foreign exchange."
Copyright This Day. Distributed by AllAfrica Global Media (allAfrica.com)., source